Clinical trial
Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD
NCT05867914
Study timeline
Study start (actual)2023-12-04Date precision: day
Registry last updated2024-02-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertension, Pulmonaryunresolved
Lung Diseases, Interstitialunresolved
Interventions
Sponsors & collaborators
Third Pole Therapeutics, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05867914 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.